Navigation Links
Cardiovascular/Renal Profile from Novascreen-a Caliper Life Sciences Company

ProductsCardiovascular/Renal Profile from Novascreen-a Caliper Life Sciences Company
Company Novascreen-a Caliper Life Sciences Company
Item Cardiovascular/Renal Profile
Price 
Description Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds.
Info Novascreen-a Caliper Life Sciences CompanyNovascreen-a Caliper Life Sciences Company
7170 Standard Drive
Hanover, Maryland
21076-1334
USA

Customer Service: 410-712-4410
Fax Number: 410-712-4412
Web Site: http://www.novascreen.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. BioProfile Chemistry Analyzer from Nova Biomedical
2. Customized Profile from Novascreen-a Caliper Life Sciences Company
3. Neurological Profile from Novascreen-a Caliper Life Sciences Company
4. Gastrointestinal Profile from Novascreen-a Caliper Life Sciences Company
5. General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company
6. CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
7. Metabolic Profiler from Bruker Daltonics
8. Cell biology services from Novascreen-a Caliper Life Sciences Company
9. Rapidplate from Caliper Life Sciences
10. Staccato Sciclone ELISA Station from Caliper Life Sciences
11. Caliper Sciclone ALH 4000 Workstation from Caliper Life Sciences
... Myeloblastosis Virus Reverse Transcriptase (AMV RT) catalyzes ... RNA or RNA:DNA hybrids (1). It requires ... than RNA primers) as well as Mg2+ ... RNase H activity. Both nonionic detergents and ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... RQ1 RNase-Free DNase is a preparation ... or double-stranded DNA to produce 3-hydroxyl ... use in applications where maintaining the ... DNase is qualified for use with ...
... Topo I, Wild Type Liquid. In ... DTT, 200 µM EDTA, 20% glycerol, pH 7.9. ... I) is a monomeric protein of 765 amino ... the relaxation of both positive and negative supercoiled ...
Biology Products:
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe , ... BioLock , an electrocardiogram (ECG) biosensor analysis ... a key IoT asset. The smart system ensures ... vehicle,s steering wheel and mobile devices to easily ... As vehicle technology advances, so too ...
(Date:11/29/2016)... BioDirection, a privately held medical device company ... detection of concussion and other traumatic brain injury (TBI), ... meeting with the U.S. Food and Drug Administration (FDA) ... During the meeting company representatives reviewed plans for clinical ... commencement of a planned pilot trial. ...
(Date:11/28/2016)... 28, 2016 "The biometric ... 16.79%" The biometric system market is in the ... the near future. The biometric system market is expected ... at a CAGR of 16.79% between 2016 and 2022. ... biometric technology in smartphones, rising use of biometric technology ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 Novogene ... services and solutions with cutting edge next-generation sequencing (NGS) ... a USD $75 Million [515 Million RMB] B round ... Capital Management ( Shenzhen ) Co., Ltd. ... Innovation") and Shanghai Sigma Square Investment Center LP ("Sigma ...
(Date:11/30/2016)... , November 30, 2016 Part of ... ... Aptuit, LLC today announced that it had ... additional 150,000 novel compounds have increased the Screening Collection to ... the hit discovery capabilities of the company. This expansion, complemented ...
(Date:11/30/2016)... ... November 30, 2016 , ... SSCI, the established leader ... the implications of the latest FDA guidance on pharmaceutical cocrystals as drug substance ... Cambridge, MA. , The event follows the successful November 15th event that ...
(Date:11/30/2016)... Park, NC (PRWEB) , ... November 30, 2016 ... ... company engaged in the development of a new orally administered treatment for Alzheimer’s ... and neuroimaging results of a Phase 2a clinical trial of T3D-959 in mild ...
Breaking Biology Technology: